Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Control-IQ 2.0 Feasibility Study #2: Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

NCT05683392 is registered in ClinicalTrials.gov with Tandem Diabetes Care, Inc. as lead sponsor.

NCT NCT05683392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05683392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Control-IQ 2.0 Feasibility Study #2: Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes
Lead sponsor
Tandem Diabetes Care, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2023
Completion date
December 13, 2023
Enrollment
72 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes